Not finding it? Sign in to also search OpenAlex live.
-
The bending of C3: Experimentally probing the l -type doubling and resonance2022 Journal of Molecular Spectroscopy article Chemistry Molecular Spectroscopy and Structure Open access
Marie‐Aline Martin‐Drumel, Qiang Zhang, Kirstin D. Doney, Olivier Pirali, M. Vervloët, Dennis W. Tokaryk, +4 more
7citations -
Oral Monotherapy with Iptacopan, a Proximal Complement Inhibitor of Factor B, Has Superior Efficacy to Intravenous Terminal Complement Inhibition with Standard of Care Eculizumab or Ravulizumab and Favorable Safety in Patients with Paroxysmal Nocturnal Hemoglobinuria and Residual Anemia: Results from the Randomized, Active-Comparator-Controlled, Open-Label, Multicenter, Phase III Apply-PNH Study
Régis Peffault de Latour, Alexander Roeth, Austin Gladston Kulasekararaj, Phillip Scheinberg, Yasutaka Ueda, Carlos M. de Castro, +15 more
23citations -
The complement alternative pathway in paroxysmal nocturnal hemoglobinuria: From a pathogenic mechanism to a therapeutic target2022 Immunological Reviews review Immunology and Microbiology Complement system in diseases Open access
Antonio Maria Risitano, Camilla Frieri, Eleonora Urciuoli, Luana Marano
52citations -
Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney2022 Frontiers in Immunology article Immunology and Microbiology Complement system in diseases Open access
Gesa Tiller, Rosa G. M. Lammerts, Jessy J. Karijosemito, Firas Farisi Alkaff, Arjan Diepstra, Robert A. Pol, +7 more
12citations -
Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis2022 Clinical Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies Open access cited by 1 patent
Hannah J. Lomax-Browne, Nicholas Medjeral‐Thomas, Sean J. Barbour, Jack Gisby, Heedeok Han, Andrew S. Bomback, +19 more
52citations -
Initial properdin binding contributes to alternative pathway activation at the surface of viable and necrotic cells2022 European Journal of Immunology article Immunology and Microbiology Complement system in diseases Open access
Mieke F. van Essen, Nicole Schlagwein, Elisa M.P. van den Hoven, Daniëlle J. van Gijlswijk‐Janssen, Rosalie Lubbers, Ramon M. van den Bos, +4 more
8citations -
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies2022 American Journal of Nephrology article Immunology and Microbiology Complement system in diseases Open access
Carla Nester, Gerald B. Appel, Andrew S. Bomback, Koenraad Peter Bouman, H. Terence Cook, Erica Daina, +14 more
70citations -
P828: NORMALIZATION OF HEMATOLOGIC AND HEALTH-RELATED QUALITY OF LIFE MARKERS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH PEGCETACOPLAN AND BASELINE HEMOGLOBIN AT OR ABOVE 10 G/DL
Jens Panse, Nicolas Daguindau, Sonia Okuyama, Régis Peffault de Latour, Philippe Schafhausen, Nicole Straetmans, +4 more
0citations
13 results